. Uteri and fetuses from female rats treated with or without fullerenol. Fullerenol was dissolved in normal saline (25.370 mg/kg body weight) and administered to female rats by tail intravenous injection for 3 consecutive days every week. After a 12-week treatment, copulations between normal males and fullerenol-treated females were initiated. Females were euthanized 18 days after treatment, and the uteri were collected. Fetal development degree was recorded. Uterus of (a) control and (b) fullerenol-treated rats. Darker color was observed after fullerenol treatment. (c) Fetal development in both groups. Smaller fetus was observed after fullerenol treatment (n = 3 in each group). Figure S2 . Immunofluorescent staining of follicle-stimulating hormone receptor (FSHR) in granulosa cells. Freshly isolated granulosa cells were routinely cultured for 4 days to attach and then fixed in paraformaldehyde (PFA). Identification with specific cell type marker FSHR indicated the high purity of granulosa cells (green, scale bar: 20 μm). Blue and red color indicate nuclear staining and F-actin skeleton, respectively. Imaging was repeated three times with similar results.
. Uteri and fetuses from female rats treated with or without fullerenol. Fullerenol was dissolved in normal saline (25.370 mg/kg body weight) and administered to female rats by tail intravenous injection for 3 consecutive days every week. After a 12-week treatment, copulations between normal males and fullerenol-treated females were initiated. Females were euthanized 18 days after treatment, and the uteri were collected. Fetal development degree was recorded. Uterus of (a) control and (b) fullerenol-treated rats. Darker color was observed after fullerenol treatment. (c) Fetal development in both groups. Smaller fetus was observed after fullerenol treatment (n = 3 in each group). . Extracellular domain-targeted anti-epidermal growth factor receptor (EGFR) antibody reduced phosphorylated-extracellular signal-regulated kinase 1 and 2 (p-ERK1/2) activation in granulosa cells. Freshly isolated oocyte-granulosa cell complexes (OGCs) were cultured in M2 medium with or without 2 μg/mL antibody for 2 h, and then granulosa cells were harvested after hyaluronidase treatment for immunoblotting analysis. Ab, extracellular domain-targeted anti-EGFR antibody. Data are shown as mean ± standard deviation (SD) from three replicates. Typical images are presented. Figure S4 . Time-course of extracellular signal-regulated kinase 1 and 2 (ERK1/2) activation in granulosa cells after fullerenol treatment. Freshly isolated oocyte-granulosa cell complexes (OGCs) were cultured in M2 medium with or without 100 μg/mL fullerenol for different times, and then granulosa cells were harvested after removing oocytes using hyaluronidase treatment for immunoblotting analysis. Data are shown as mean ± standard deviation (SD) from three replicates. Typical images are presented. Figure S5 . Characterization of fullerenol nanoparticles using atomic force microscopy (AFM). Fullerenol nanoparticles were dissolved in phosphate-buffered saline (PBS) and ultrasonically processed. Newly cleaved mica was pretreated with 0.1 M magnesium chloride (MgCl2), rinsed with deionized water and then dried before nanoparticles deposition. AFM (Agilent 5500, Santa Clara, CA, USA) imaging was performed under air condition and AC mode (tapping mode). High-quality (HQ): NSC15/ALBS probes with nominal spring constant of K = 40 N/m from Mikromasch probes were used. Settings: amplitude, 3-6 V; speed, 0.8 ln/s; scan size, 10 × 10 μm; and range, 1.5 μm. Images were processed off-line using inherent PicoImage software. 
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